Почетна › Dijabetes tipa 2 › Пенсилванија
Kliničke studije za Dijabetes tipa 2 u državi Пенсилванија
33 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Пенсилванија.
Gradovi u državi Пенсилванија
Zvanični tekst studije (na engleskom)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Heritage Valley Medical Group, Beaver
- Preferred Primary Care Physicians-Pittsburgh-63932, Pittsburgh
- Preferred Primary Care Physicians, Pittsburgh
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Tristar Clinical Investigations, Philadelphia
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Heritage Valley Medical Group, Beaver
- Capital Area Research, LLC, Camp Hill
- Thomas Jefferson University, Philadelphia
- и још 8
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Smithfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- VA Pittsburgh Healthcare System, Pittsburgh
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Frontier Clinical Research, LLC, Smithfield
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 5. 11. 2026. · NCT07668336A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
- Preferred Primary Care Physicians, Uniontown
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Frontier Clinical Research, LLC, Scottdale
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Scottdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Northeast Clinical Research Center, Bethlehem
- Suburban Research Associates, West Chester
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Feasterville-Trevose
- Research Site, Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Children's Hosptl Philadelphia, Philadelphia
Тражи се учесникФаза 3
Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Preferred Primary Care Physicians, Inc., Uniontown
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Тражи се учесник
Узраст од 14 до 26 · Оба пола · Ажурирано 7. 10. 2026. · NCT06375460Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Suburban Research Associates, West Chester
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Heritage Valley Medical Group, Beaver
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07564414A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Capital Area Research, Camp Hill
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418Phenotyping Genetic Risk for Type 2 Diabetes
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
Тражи се учесникЗдраве особе су добродошле
Узраст од 10 до 70 · Оба пола · Ажурирано 21. 9. 2026. · NCT04024631A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Philadelphia
- AURORA-2 Clinical Site, Pittsburgh
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Heritage Valley Medical Group, Beaver
- Capital Area Research LLC, Newport
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122Pharmacogenetics of Response to GLP1R Agonists
- Amish Research Clinic, Lancaster
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 89 · Оба пола · Ажурирано 27. 7. 2026. · NCT05071898CGM for Management of Type 2 Diabetes in Pregnancy
- University of Pennsylvania, Philadelphia
Тражи се учесник
Узраст од 18 до 50 · Жене · Ажурирано 29. 6. 2026. · NCT06628453Sleep and Glycemic Control in Type 2 Diabetes Adolescents
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесник
Узраст од 12 до 20 · Оба пола · Ажурирано 29. 6. 2026. · NCT04213547DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Children's Hospital of Philadelphia, Philadelphia
Тражи се учесникОпсервациона студија
Узраст од 8 до 15 · Оба пола · Ажурирано 7. 5. 2026. · NCT06525259Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Тражи се учесникЗдраве особе су добродошле
Узраст 13 и старији · Оба пола · Ажурирано 27. 4. 2026. · NCT07216118Transformative Research in Diabetic Nephropathy 2.0
- Penn Presbyterian Medical Center, Philadelphia
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 2. 3. 2026. · NCT07444203Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
- Children's Hospital of Pittsburgh, Pittsburgh
Тражи се учесник
Узраст од 16 до 24 · Оба пола · Ажурирано 20. 2. 2026. · NCT07270016Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 12 до 17 · Оба пола · Ажурирано 18. 12. 2025. · NCT05277558CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
- Thomas Jefferson University, Philadelphia
Тражи се учесник
Узраст 18 и старији · Жене · Ажурирано 14. 10. 2025. · NCT07184775Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
- Reading Hospital, an affiliate of Tower Health, West Reading
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 30. 7. 2025. · NCT05893927Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.